Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
Researchers identify new mechanism associated with p53 mutation

Researchers identify new mechanism associated with p53 mutation

Researchers discover glioblastoma origins using brain organoids

Researchers discover glioblastoma origins using brain organoids

Mount Sinai awarded more than $10 million in federal funding for research on glioblastoma

Mount Sinai awarded more than $10 million in federal funding for research on glioblastoma

Lab-grown brain organoids may hold the answers to personalized treatments for glioblastomas

Lab-grown brain organoids may hold the answers to personalized treatments for glioblastomas

Immunosupressant combination therapy for glioblastoma shows promise

Immunosupressant combination therapy for glioblastoma shows promise

NFCR-funded translational cancer research project receives $700,000 from Virginia Catalyst

NFCR-funded translational cancer research project receives $700,000 from Virginia Catalyst

Discovery of novel mechanism by which certain breast cancers can metastasize

Discovery of novel mechanism by which certain breast cancers can metastasize

Scientists use novel technology for opening blood-brain barrier with implantable ultrasound

Scientists use novel technology for opening blood-brain barrier with implantable ultrasound

Important biomarker may help in determining prognosis of brain cancer patients

Important biomarker may help in determining prognosis of brain cancer patients

UPV researchers develop new methodology to monitor patients with glioblastoma

UPV researchers develop new methodology to monitor patients with glioblastoma

Newer safer way to effectively treat deadly brain cancer

Newer safer way to effectively treat deadly brain cancer

Researchers develop new strategy for treating the most aggressive type of brain cancer

Researchers develop new strategy for treating the most aggressive type of brain cancer

Extra DNA scooped up alongside cancer-causing genes helps drive tumor growth

Extra DNA scooped up alongside cancer-causing genes helps drive tumor growth

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

Cell factors decide if a cancer grows or dies, says new study

Cell factors decide if a cancer grows or dies, says new study

Study on sea sponge opens up possibilities to create new antitumor drugs

Study on sea sponge opens up possibilities to create new antitumor drugs

Researchers identify potential drug targets for glioblastoma

Researchers identify potential drug targets for glioblastoma

Liquid biopsy can predict prognosis in patients with glioblastoma

Liquid biopsy can predict prognosis in patients with glioblastoma

NYU researcher awarded $1.7 million NIH grant to optimize cancer treatment

NYU researcher awarded $1.7 million NIH grant to optimize cancer treatment

Coaxial electrospinning could lead to new medical innovations

Coaxial electrospinning could lead to new medical innovations